Complete Filing Data
Wellgistics Health, Inc. reported Stockholders Equity of -$12.45 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Wellgistics Health, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Net Income Loss | -$101.3M | -$6.9M | -$2.9M |
| Operating Income Loss | -$93.7M | -$6.1M | -$2.9M |
| Operating Expenses | $87.3M | $7.9M | $2.9M |
| Nonoperating Income Expense | -$7.5M | -$711.1K | -$15.1K |
| Interest Expense Nonoperating | $4.6M | $831.5K | $15.1K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$101.3M | -$6.9M | -$2.9M |
| General And Administrative Expense | $70.3M | $6.8M | $2.9M |
| Revenue From Contract With Customer Excluding Assessed Tax | $23.3M | $18.1M | |
| Gross Profit | -$6.4M | $1.8M | |
| Cost Of Revenue | $29.8M | $16.4M | |
| Other Nonoperating Income | $42.0K | $120.4K | |
| Selling And Marketing Expense | $1.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Net Income Loss | -$34.3M | -$6.7M | -$32.4M | -$1.9M | -$574.3K | -$83.1K |
| Operating Income Loss | -$31.5M | -$5.5M | -$31.3M | -$1.7M | -$573.0K | -$79.8K |
| Operating Expenses | $31.8M | $6.0M | $32.0M | $2.3M | $570.4K | $79.8K |
| Nonoperating Income Expense | -$2.8M | -$1.2M | -$1.1M | -$122.2K | -$1.3K | -$3.4K |
| Interest Expense Nonoperating | $1.4M | $1.2M | $1.1M | $137.6K | $1.3K | $3.4K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$34.3M | -$6.7M | -$32.4M | -$1.9M | -$574.3K | -$83.1K |
| General And Administrative Expense | $30.2M | $4.9M | $31.2M | $1.8M | $570.4K | $79.8K |
| Revenue From Contract With Customer Excluding Assessed Tax | $3.0M | $7.8M | $10.9M | $5.7M | $44.5K | |
| Gross Profit | $231.0K | $505.8K | $692.6K | $521.2K | -$2.6K | |
| Cost Of Revenue | $2.8M | $7.3M | $10.2M | $5.2M | $47.1K | |
| Other Nonoperating Income | $9.1K | $12.0K | $12.0K | $15.4K | ||
| Selling And Marketing Expense | $803.7K | $343.4K | $65.2K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Stockholders Equity | -$12.4M | $6.7M | -$2.9M | -$5.3K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $42.6K | $1.0M | $1.4K | |
| Retained Earnings Accumulated Deficit | -$111.0M | -$9.8M | -$2.9M | |
| Liabilities Current | $29.8M | $38.0M | $2.9M | |
| Liabilities And Stockholders Equity | $30.5M | $57.3M | $338.4K | |
| Liabilities | $42.9M | $50.6M | $3.2M | |
| Common Stock Value | $10.1K | $5.1K | $4.5K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$985.8K | $1.0M | $1.4K | |
| Cash And Cash Equivalents At Carrying Value | $42.6K | $1.0M | $1.4K | |
| Assets Current | $2.8M | $15.2M | $338.4K | |
| Assets | $30.5M | $57.3M | $338.4K | |
| Accrued Liabilities And Other Liabilities | $6.4M | $4.3M | $1.8M | |
| Secured Debt Current | $10.9M | $11.9M | ||
| Property Plant And Equipment Net | $229.4K | $388.2K | ||
| Other Intangible Assets Net | $10.3M | $20.7M | ||
| Operating Lease Right Of Use Asset | $966.9K | $1.5M | ||
| Operating Lease Liability Noncurrent | $527.1K | $1.1M | ||
| Operating Lease Liability Current | $569.3K | $519.5K | ||
| Inventory Net | $1.6M | $9.5M | ||
| Goodwill | $14.2M | $16.2M | ||
| Deposits Assets | $85.0K | $85.0K | ||
| Other Assets Noncurrent | $1.4M | |||
| Notes And Loans Receivable Net Noncurrent | $139.8K | |||
| Repayments Of Notes Payable | $137.1K | $135.8K | ||
| Long Term Loans Payable | $55.1K | |||
| Deferred Costs Current | $875.4K | |||
| Stock Issued During Period Value Common Stock Issued Pursuant To Equity Purchase Agreement | $2.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Stockholders Equity | $6.8M | $905.3K | $4.5M | $10.0M | -$3.1M | -$3.0M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $4.2M | $419.9K | $2.5M | $793.1K | $67.0K | $292.6K |
| Retained Earnings Accumulated Deficit | -$83.2M | -$48.9M | -$42.2M | |||
| Liabilities Current | $32.7M | $42.4M | $46.2M | |||
| Liabilities And Stockholders Equity | $52.8M | $54.2M | $58.1M | |||
| Liabilities | $46.0M | $53.3M | $53.6M | |||
| Common Stock Value | $8.9K | $6.3K | $6.1K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $1.5M | $291.2K | ||||
| Cash And Cash Equivalents At Carrying Value | $4.2M | $419.9K | $2.5M | |||
| Assets Current | $12.8M | $13.5M | $16.6M | |||
| Assets | $52.8M | $54.2M | $58.1M | |||
| Accrued Liabilities And Other Liabilities | $5.5M | $5.5M | $4.8M | |||
| Secured Debt Current | $12.2M | $13.2M | $17.7M | |||
| Property Plant And Equipment Net | $268.9K | $308.6K | $348.4K | |||
| Other Intangible Assets Net | $18.5M | $19.2M | $20.0M | |||
| Operating Lease Right Of Use Asset | $1.0M | $1.3M | $1.4M | |||
| Operating Lease Liability Noncurrent | $660.5K | $816.2K | $959.0K | |||
| Operating Lease Liability Current | $503.4K | $546.3K | $532.7K | |||
| Inventory Net | $7.5M | $9.0M | $9.7M | |||
| Goodwill | $16.2M | $16.2M | $16.2M | |||
| Deposits Assets | $150.0K | $85.0K | $85.0K | |||
| Other Assets Noncurrent | $1.5M | $1.4M | $1.4M | |||
| Notes And Loans Receivable Net Noncurrent | $139.8K | $139.8K | $139.8K | |||
| Repayments Of Notes Payable | $68.6K | |||||
| Long Term Loans Payable | ||||||
| Deferred Costs Current | ||||||
| Stock Issued During Period Value Common Stock Issued Pursuant To Equity Purchase Agreement | $1.7M | $1.1M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$10.9M | -$1.2M | -$349.1K |
| Net Cash Provided By Used In Financing Activities | $10.8M | $1.8M | $350.5K |
| Increase Decrease In Related Parties Net | -$321.1K | -$3.3M | $269.2K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $3.2M | $1.6M | $1.8M |
| Increase Decrease In Accounts Payable | $2.2M | -$882.3K | $1.0M |
| Share Based Compensation | $54.8M | $1.1M | |
| Proceeds From Issuance Initial Public Offering | $4.0M | ||
| Payments To Acquire Intangible Assets | $881.5K | $377.3K | |
| Net Cash Provided By Used In Investing Activities | -$881.5K | $469.1K | |
| Increase Decrease In Operating Lease Liability | $41.7K | $22.1K | |
| Increase Decrease In Inventories | -$1.9M | $72.4K | |
| Increase Decrease In Accounts Receivable | -$799.8K | $40.1K | |
| Proceeds From Merchant Cash Advance | $1.5M | $1.3M | |
| Proceeds From Issuance Offering Costs | -$810.6K | -$162.3K | |
| Increase Decrease In Prepaid Expense | -$524.00 | -$11.4K | |
| Proceeds From Repayments Of Lines Of Credit | $20.1M | $756.5K | |
| Increase Decrease In Other Operating Assets | $587.5K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 |
|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$1.3M | $31.2K |
| Net Cash Provided By Used In Financing Activities | $3.1M | $260.0K |
| Increase Decrease In Related Parties Net | $87.0K | -$112.7K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $474.5K | -$31.6K |
| Increase Decrease In Accounts Payable | $1.9M | $81.7K |
| Share Based Compensation | $27.8M | |
| Proceeds From Issuance Initial Public Offering | $4.0M | |
| Payments To Acquire Intangible Assets | $273.1K | |
| Net Cash Provided By Used In Investing Activities | -$273.1K | |
| Increase Decrease In Operating Lease Liability | -$1.3K | |
| Increase Decrease In Inventories | $214.5K | |
| Increase Decrease In Accounts Receivable | $180.1K | |
| Proceeds From Merchant Cash Advance | $471.2K | |
| Proceeds From Issuance Offering Costs | -$1.6M | |
| Increase Decrease In Prepaid Expense | $334.8K | |
| Proceeds From Repayments Of Lines Of Credit | -$310.6K | |
| Increase Decrease In Other Operating Assets |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 71.0M | 47.3M | 44.7M |
| Weighted Average Number Of Diluted Shares Outstanding | 71.0M | 47.3M | 44.7M |
| Earnings Per Share Diluted | $-1.43 | $-0.15 | $-0.06 |
| Earnings Per Share Basic | $-1.43 | $-0.15 | $-0.06 |
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 101.3M | 51.1M | 44.7M |
| Common Stock Shares Issued | 102.3M | 51.1M | 44.7M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 74.4M | 61.8M | 51.9M | 48.4M | 45.9M | 44.7M |
| Weighted Average Number Of Diluted Shares Outstanding | 74.4M | 61.8M | 51.9M | 48.4M | 45.9M | 44.7M |
| Earnings Per Share Diluted | $-0.46 | $-0.11 | $-0.62 | $-0.04 | $-0.01 | $0.00 |
| Earnings Per Share Basic | $-0.46 | $-0.11 | $-0.62 | $-0.04 | $-0.01 | $0.00 |
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Outstanding | 89.5M | 63.1M | 61.5M | |||
| Common Stock Shares Issued | 91.4M | 72.9M | 71.7M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Depreciation | $158.8K | $67.6K | |
| Depreciation And Amortization | $3.2M | $1.1M | |
| Additional Paid In Capital | $98.6M | $16.5M | -$4.0K |
| Provision For Doubtful Accounts | $927.6K | $93.4K | |
| Prepaid Expense Current | $524.00 | ||
| Adjustment For Amortization | $3.1M | $1.0M | |
| Stock Issued During Period Value Vested Restricted Stock Granted To Employees | $1.5M | ||
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $2.3M | ||
| Interest Paid Net | $3.1M | $332.8K | |
| Capitalized Computer Software Net | $1.9M | $1.6M | |
| Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | $3.1M | ||
| Stock Issued During Period Value Pursuant To Business Combinations | $15.4M | ||
| Stock Issued During Period Value New Issues | $4.0M | $500.00 | |
| Stock Issued During Period Value Vested Restricted Stock Granted To Directors | $24.3M | ||
| Stock Issued During Period Value Other | $543.5K | ||
| Stock Issued During Period Value Issued For Services | $546.0K | $680.8K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|
| Depreciation | $39.7K | $39.7K | $39.8K | $27.2K | $0.00 |
| Depreciation And Amortization | $802.8K | $802.8K | $802.9K | $467.4K | |
| Additional Paid In Capital | $89.9M | $49.8M | $46.7M | ||
| Provision For Doubtful Accounts | $65.1K | $76.2K | $26.7K | ||
| Prepaid Expense Current | $525.00 | $65.5K | $335.3K | ||
| Adjustment For Amortization | $763.1K | ||||
| Stock Issued During Period Value Vested Restricted Stock Granted To Employees | $785.0K | $354.6K | $75.6K | ||
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $249.0K | $499.3K | $1.6M | ||
| Interest Paid Net | $616.1K | ||||
| Capitalized Computer Software Net | $2.2M | $2.0M | |||
| Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | $85.5K | $2.9M | |||
| Stock Issued During Period Value Pursuant To Business Combinations | $15.0M | $400.0K | |||
| Stock Issued During Period Value New Issues | $4.0M | ||||
| Stock Issued During Period Value Vested Restricted Stock Granted To Directors | $24.3M | ||||
| Stock Issued During Period Value Other | $543.5K | ||||
| Stock Issued During Period Value Issued For Services | $546.0K |
Most recent annual filing with the SEC: March 20, 2026
Data sourced from SEC EDGAR public filings as of August 8, 2026.